Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 27 February, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of MK Proteins Ltd

About the Company - MK Proteins Ltd

M K Proteins Ltd. is a Public Limited Listed company incorporated on 15/06/2012 and has its registered office in the State of Haryana, India. Company’s Corporate Identification Number(CIN) is L15500HR2012PLC046239 and registration number is 046239. Currently company belongs to the Industry of Edible Oils & Solvent Extraction. Company’s Total Operating Revenue is Rs. 255.89 Cr. and Equity Capital is Rs. 4.17 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Edible Oils & Solvent ExtractionNaraingarh Road, Vill. Garnala, Ambala District Haryana 134003info@mkproteins.in
http://www.mkproteins.in
Management
NamePosition Held
Mr. Vinod KumarExecutive Director
Mr. Raj KumarNon Exe.Non Ind.Director
Mr. Parvind KumarNon Executive Director
Mr. Parmod KumarManaging & Executive Director
Ms. Laxmi MandalInd. Non-Executive Director
Mr. Tej Mohan SinghInd. Non-Executive Director
Mrs. Shipra JainInd. Non-Executive Director
Mr. Swati GuptaInd. Non-Executive Director

M K Proteins Ltd. Share Price Update

Share PriceValue
Today₹45.30
Previous Day₹45.42

Basic Stock Data of MK Proteins Ltd

Market Cap 548 Cr.
Current Price 43.8
High / Low100/35.0
Stock P/E
Book Value 4.25
Dividend Yield0.00 %
ROCE19.1 %
ROE23.7 %
Face Value 1.00

Data Source: screener.in

MK Proteins Ltd Quarterly Results

MonthMar 2017Jun 2023Sep 2023
Sales53.5976.2013.64
Expenses51.6972.2113.00
Operating Profit1.903.990.64
OPM %3.55%5.24%4.69%
Other Income0.010.000.03
Interest0.690.520.04
Depreciation0.300.120.12
Profit before tax0.923.350.51
Tax %36.96%25.67%21.57%
Net Profit0.572.490.41
EPS in Rs0.070.200.03

MK Proteins Ltd Quarterly Chart

MK Proteins Ltd Profit & Loss

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Sales85122123145165172157194311256315
Expenses84119119141160166152189295240298
Operating Profit23445655161617
OPM %2%2%3%3%3%3%3%2%5%6%5%
Other Income00000000000
Interest12222222112
Depreciation00111111111
Profit before tax11112222141415
Tax %33%33%32%31%35%35%28%26%27%27%27%
Net Profit10111122101011
EPS in Rs2.522.334.003.430.120.110.130.150.830.810.85
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%

MK Proteins Ltd Profit & Loss Yearly Chart

MK Proteins Ltd Growth

Compounded Sales Growth
10 Years:14%
5 Years:13%
3 Years:17%
TTM:23%
Compounded Profit Growth
10 Years:35%
5 Years:49%
3 Years:81%
TTM:5%
Stock Price CAGR
10 Years:%
5 Years:79%
3 Years:158%
1 Year:-38%
Return on Equity
10 Years:25%
5 Years:25%
3 Years:30%
Last Year:24%

MK Proteins Ltd Balance Sheet

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital11113444441313
Reserves1123211131525353841
Borrowings18282026313326312537457
Other Liabilities221310128471310107
Total Liabilities2132353947564757678610568
Fixed Assets336776432322
CWIP030000000000
Investments000000000003
Other Assets1826293240504353658310363
Total Assets2132353947564757678610568

MK Proteins Ltd Reserves and Borrowings Chart

MK Proteins Ltd Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity -14-511-4-4-126-46-10-8
Cash from Investing Activity -4-3-0-2-1-000-0-20
Cash from Financing Activity 188-106512-74-5128
Net Cash Flow0-0-00-00-00-000

MK Proteins Ltd Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days3219162710392518244219
Inventory Days4062705783697579488091
Days Payable6639222312681086
Cash Conversion Cycle657547627097948962114104
Working Capital Days646947546089898660104106
ROCE %10%14%13%12%11%8%8%29%23%19%

MK Proteins Ltd Financial Efficiency Indicators Chart

MK Proteins Ltd Share Holding Pattern

MonthMar 2019Jun 2019Sep 2019Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Jun 2023Sep 2023
Promoters64.95%64.95%74.82%74.82%74.82%74.82%74.82%74.82%74.82%74.82%74.82%74.82%
Public35.05%35.06%25.18%25.17%25.17%25.18%25.18%25.18%25.18%25.18%25.17%25.17%
No. of Shareholders7878586044344257871503441,454

MK Proteins Ltd Shareholding Pattern Chart

No. of MK Proteins Ltd Shareholders

This stock is not held by any mutual fund

MK Proteins Ltd ROCE Trend

MK Proteins Ltd EPS Trend

MK Proteins Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)8.5124.4224.914.363.94
Diluted EPS (Rs.)8.5124.4224.914.363.94
Cash EPS (Rs.)9.1126.6127.097.166.87
Book Value[Excl.RevalReserv]/Share (Rs.)40.1894.9570.3445.4341.10
Book Value[Incl.RevalReserv]/Share (Rs.)40.1894.9570.3445.4341.10
Revenue From Operations / Share (Rs.)251.64613.52745.89465.43375.88
PBDIT / Share (Rs.)13.6637.8538.3112.2412.10
PBIT / Share (Rs.)13.0635.6636.139.439.16
PBT / Share (Rs.)11.6733.6734.345.865.48
Net Profit / Share (Rs.)8.5124.4224.914.363.94
PBDIT Margin (%)5.426.165.132.633.21
PBIT Margin (%)5.185.814.842.022.43
PBT Margin (%)4.635.484.601.251.45
Net Profit Margin (%)3.383.983.330.931.04
Return on Networth / Equity (%)21.1725.7135.419.589.58
Return on Capital Employeed (%)30.8735.1344.5317.1420.44
Return On Assets (%)10.1411.8215.423.213.47
Long Term Debt / Equity (X)0.050.060.150.200.08
Total Debt / Equity (X)0.880.920.831.611.51
Asset Turnover Ratio (%)3.303.335.023.743.03
Current Ratio (X)1.961.881.921.571.48
Quick Ratio (X)0.580.740.790.410.45
Inventory Turnover Ratio (X)4.234.495.774.973.60
Interest Coverage Ratio (X)9.8618.9621.313.423.28
Interest Coverage Ratio (Post Tax) (X)7.1413.2314.862.222.07
Enterprise Value (Cr.)957.87116.6557.7260.0856.99
EV / Net Operating Revenue (X)3.040.450.180.300.36
EV / EBITDA (X)56.037.393.6111.7711.30
MarketCap / Net Operating Revenue (X)2.900.310.100.150.19
Price / BV (X)18.172.021.131.571.81
Price / Net Operating Revenue (X)2.900.310.100.150.19
EarningsYield0.010.120.310.060.05

MK Proteins Ltd Profitability Ratios (%)

MK Proteins Ltd Liquidity Ratios

MK Proteins Ltd Liquidity Ratios (%)

MK Proteins Ltd Interest Coverage Ratios (%)

MK Proteins Ltd Valuation Ratios

Fair Value of MK Proteins Ltd Stock

Fair Value: ₹15.41

The stock is overvalued by 64.82% compared to the current price ₹43.8

*Investments are subject to market risks

Strength and Weakness of MK Proteins Ltd Stock

StrengthWeakness
  1. The company has shown consistent growth in sales (185.91 cr) and profit (5.00 cr) over the years.
  1. The stock is trading at a high valuation with an average P/B ratio of 20.69 and average Dividend Yield of 3.48%.
  2. The stock has a low average ROCE of 13.36%, which may not be favorable.
  3. The stock has a high average Working Capital Days of 75.27, which may not be favorable.
  4. The stock has a high average Cash Conversion Cycle of 79.91, which may not be favorable.
  5. The company has higher borrowings (27.25) compared to reserves (15.58), which may suggest financial risk.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in MK Proteins Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE